(NASDAQ: CRBU) Caribou Biosciences's forecast annual revenue growth rate of 31.37% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.08%, and while it is forecast to beat the US market's average forecast revenue growth rate of 13.19%.
Caribou Biosciences's revenue in 2026 is $11,159,000.On average, 10 Wall Street analysts forecast CRBU's revenue for 2026 to be $1,095,962,508, with the lowest CRBU revenue forecast at $947,044,580, and the highest CRBU revenue forecast at $1,217,628,745. On average, 9 Wall Street analysts forecast CRBU's revenue for 2027 to be $1,215,792,638, with the lowest CRBU revenue forecast at $1,077,987,988, and the highest CRBU revenue forecast at $1,522,035,932.
In 2028, CRBU is forecast to generate $2,699,463,601 in revenue, with the lowest revenue forecast at $1,088,811,355 and the highest revenue forecast at $10,146,906,210.